Yttrium90-TARE with or without chemotherapy may improve survival in patients with locally advanced unresectable intrahepatic cholangiocarcinoma.

Discov Oncol · 2025 · PMC12283486 · PMID 40694260

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

After adjusting for age, AJCC stage, ECOG performance status, and tumor focality, there was a trend toward longer PFS and OS among those treated with y90 TARE, but this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.